Global Search | Novartis United Kingdom

Sort by

Relevance

Newest first

Oldest first

Hide Filters

Showing 236 results

Meet the MPN 10
Help get your CML back on track
Product related issues
Well-being
Mission
Moments that count
Media Release / Feb 04, 2025

Novartis Kisqali® (ribociclib) receives MHRA authorisation for the adjuvant treatment of HR+/HER2- early breast cancer at high risk of recurrence in a broad population of patients

The Medicines and Healthcare products Regulatory Agency (MHRA) have authorised a new indication for ribociclib as an adjuvant treatment option to be used in combination with an aromatase inhibitor (…
Swansea Bay University Health Board
The Royal Marsden NHS Foundation Trust, Fulham Road, London SW3 6JJ
Mid and South Essex NHS Foundation Trust – Basildon trust

‹ Previous page
1
…
14
15
16
17
18
19
20
…
24
› Next page